期刊文献+

早期子宫内膜癌保留生育功能的治疗 被引量:10

Fertility-sparing treatment of early endometrial cancer
原文传递
导出
摘要 手术治疗仍是治疗子宫内膜癌(包括重度不典型增生)的标准方法。虽然可取得良好的治疗效果,但术后患者会丧失生育能力,这会对患者的生存质量和社会-心理状态造成严重影响。该文以近期FIGO肿瘤报告和NCCN最新版指南为基础,总结了子宫内膜癌保留生育功能治疗方法的进展和我院的治疗经验。 Women with endometrial carcinoma have an excellent chance of a cure by undergoing total hysterectomy with bilateral salpingo-oophorectomy. However, many young patients wish to preserve fertility and radical surgery has an adverse effect on their quality of life. Successful hormonal therapy for the early endometrial carcinoma to preserve fertility has been reported. There is a therapeutic dilemma regarding the conservative management. Based on the FIGO cancer report and NCCN guideline, we analyze current evidence about fertility-sparing treatment.
作者 李晶 林仲秋
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2013年第5期332-334,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 子宫内膜癌 保留生育功能 孕激素 endometrial carcinoma fertility-sparing treatment progestins
  • 相关文献

参考文献15

  • 1Denny L,Quinn M, Hacker N. FIGO Cancer Report 2012 [ J]. Int J Gynaecol Obstet, 2012,119 ( Suppl 2 ) : $89.
  • 2Greer BE, Koh WJ, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology[ J]. J Natl Compr Canc Netw, 2009,7 ( 5 ) :498-531.
  • 3Zivanovic O, Carter J, Kauff ND, et al. A review of the challen- ges faced in the conservative treatment of young women with en- dometrial carcinoma and risk of ovarian cancer[ J]. Gynecol On- col, 2009,115(3) :504-509.
  • 4Sorosky JI. Endometrial cancer[ J]. Obstet Gynecol, 2008,111 (2 Pt 1 ) :436-447.
  • 5Mao Y, Wan X, Chen , et al. Outcomes of conservative thera- py for young women with early endometrial adenocarcinoma [ J ]. Fertil Steril, 2010,93 ( 1 ) :283-285.
  • 6Kim MK, Yoon BS, Park H, et al. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine sys- tem for early-stae endometrial cancer in youn women: pilotstudy[J]. Int J Gynecol Cancer, 2011,21 (4) :673-677.
  • 7Yamazawa K, Hirai M, Fujito A, et al. Fertility-preserving treat- ment with progestin, and pathological criteria to predict respon- ses, in young women with endometrial cancer[ J]. Hum Reprod, 2007,22 (7) : 1953-1958.
  • 8Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer [ J ]. Expert Rev Anticancer T- her, 2006,6( 1 ) :27-32.
  • 9Benshushan A. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment [ J ]. Eur J Obstet Gynecol Reprod Biol, 2004,117(2) :132-137.
  • 10Yang YC, Wu CC, Chen CP, et al. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer [ J]. Gynecol Oncol, 2005,99(2) :287-295.

同被引文献78

  • 1Collinson AC, Ngom PT, Moore SE, et al. Birth season and environ- mental influences on blood leucocyte and lymphocyte subpopula- tions in rural Cambian infants[J]. BMC Immunology,2008,9:18.
  • 2Edris F, Vilos G A, A1-Mubarak A, et al. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with a- typical endometrial hyperplasia [ J ]. J Minim Invasive Gynecol, 2007,14( 1 ) :68-73.
  • 3Gunderson CC, Fader AN, Carson KA,et al. Oncologic and repro- ductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma:a system review[ J]. Gy- necol Onco1,2012,125 (2) :477-482.
  • 4Arora V, Quinn MA. Endometrial cancer [ J ]. Best Pract Res Clin Obstet Gynaecol,2012,26(3 ) :311-324.
  • 5Walsh C, Holschneider C, Hoang Y. Conexisting ovarian malig- nancy in young women with endometrial cancar[ J]. Obstet Gynae- col, 2005,106 ( 4 ) : 693-699.
  • 6Dorais J, Dodson M, Calvert J, et al. Fertility-sparing management of endometrial adenoeareinoma [ J ]. Obstet Gyneeol Surv, 2011,66 (7) :443-451.
  • 7Karimi-Zarehi M, Mousavi AS, Behtash N, et al. Conservative management of young women with endometrial carcinoma or com- plex atypical hyperplasia:report of three eases and literature re- view[J]. Eur J Gynaecol Oneol,2011,32(6) :695-698.
  • 8KESTERSON J P, FANNING J. Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls [ J ]. J Gynecol Oncol,2012,23 (2) : 120-124.
  • 9GERLI S, SPAN0 F, di RENZO G C. Endometrial carcinoma in women 40 year old or younger : a case report and literature review [ J ]. Eur Rev Med Pharmacol Sci, 2014, 18 ( 14 ) : 1973-1978.
  • 10ZHAO S,LI G,YANG L,et al. Response-specific progestin resist- ance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogest- erone acetate[J]. Oncol Lett,2013,5( 1 ) :139-144.

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部